Medical technology company Gradient Health announced a landmark collaboration with not-for-profit health system Cone Health, helping to accelerate the innovation of health care technology.
Representation matters when it comes to artificial intelligence. That’s why Cone Health has ensured their patients don’t get left behind by the latest advances in medical technology by collaborating with innovators all over the world through Gradient Health’s transformative research platform.
Also Read: UST Earns Azure Expert MSP Recognition from Microsoft
Gradient Health, via its platform, provides leading medical researchers with access to the data they need to engineer more equitable and representative products for patients. Such innovations have contributed to advances in care for people suffering from a range of conditions including lung cancer, aneurysm, subdural hemorrhage, cervical spine cancer, and many more.
By connecting to Gradient’s and leveraging previously unused assets, Cone Health and Gradient are helping to advance medical care for millions of people, with dozens of diseases.
David Heenan at Cone Health Ventures commented “What Gradient Health is doing is truly revolutionary and we believe will accelerate the next generation of advanced medical technology to the bedside so that Cone Health can continue to provide excellent, cutting-edge care to our patients.”
Josh Miller, Chief Executive Officer at Gradient Health said of the collaboration “This will enable Gradient to provide researchers with the insights they need to build life-saving products for patients”.
SOURCE: PR Newswire